trending Market Intelligence /marketintelligence/en/news-insights/trending/hbzx5xk-xkjpu02h2pxh1g2 content esgSubNav
In This List

QRxPharma adds director to board

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


QRxPharma adds director to board

QRxPharma Ltd. appointed Anthony Jefferies to its board.

Jefferies is a partner at Gillis Delaney Lawyers.

Australia's QRxPharma develops pain medications.